Pg. Scott et al., FIBROBLASTS FROM POSTBURN HYPERTROPHIC SCAR TISSUE SYNTHESIZE LESS DECORIN THAN NORMAL DERMAL FIBROBLASTS, Clinical science, 94(5), 1998, pp. 541-547
1. Fibroblast cultures were established from biopsies of hypertrophic
scar and normal dermis taken from nine patients recovering from second
- and third-degree burns. The capacity of these fibroblasts to synthes
ize the small proteoglycan decorin was assessed by quantitative Wester
n blot analysis of conditioned medium collected from confluent culture
s. Levels of mRNA for decorin were assessed by quantitative Northern a
nalysis, Since transforming growth factor-beta 1 is implicated in vari
ous fibrotic conditions, including post-burn hypertrophic scar, its ef
fect on decorin synthesis by these paired fibroblast cell strains was
assessed. 2. Production of decorin was lower in all cell strains of hy
pertrophic scar fibroblasts tested, compared with normal dermal fibrob
lasts cultured from the same patients (mean 49 +/- 23 %; P < 0.001, n
= 9), Levels of mRNA for decorin were also lower (mean 59 +/- 28 %; P
< 0.02, n = 7) but those for biglycan and versican were not significan
tly different. Four pairs of cell strains were examined at more than o
ne passage and the differences in decorin protein were found to be phe
notypically persistent. Treatment of confluent cultures with transform
ing growth factor-beta 1 for 3 days caused a reduction in both decorin
protein and mRNA in all six strains of hypertrophic scar fibroblasts
tested and in five of six strains of normal dermal fibroblasts, An inc
rease in the length of the dermatan sulphate chain on decorin, a previ
ously reported characteristic of this glycosaminoglycan in hypertrophi
c scar, was seen in all but two of the strains treated with transformi
ng growth factor-beta 1. The depression of decorin synthesis by transf
orming growth factor-beta 1 was reversed on removal of the agent and p
assaging the fibroblasts. 3. The reduced capacity of fibroblasts in hy
pertrophic scar tissue to synthesize decorin may have implications for
the development of the condition since this small proteoglycan is inv
olved in tissue organization and may also play a role in modulating th
e activity in vivo of fibrogenic cytokines such as transforming growth
factor-beta 1.